Wordt geladen...
A Randomized Controlled Double-Masked Trial of Albuterol Add-on Therapy in Patients With Multiple Sclerosis
BACKGROUND: Interleukin 12 (IL-12), a cytokine that promotes generation of helper T cells subtype 1, is increased in multiple sclerosis. Albuterol sulfate, a β2-adrenergic agonist, reduces IL-12 expression, so we tested the effect of albuterol as an add-on treatment to glatiramer acetate therapy. OB...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2010
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2954052/ https://ncbi.nlm.nih.gov/pubmed/20837847 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/archneurol.2010.222 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|